Lyell Immunopharma Inc

NASDAQ:LYEL 3:59:54 PM EDT

13.25

-1.26 (-8.68%)

Market Cap (Intraday)	3.17B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.51 Million
Adjusted EPS	-$0.52

See more estimates

10-Day MA	$15.21
50-Day MA	$15.45
200-Day MA	N/A

See more pivots

Lyell Immunopharma Inc Stock, NASDAQ:LYEL

400 East Jamie Court, Suite 301, South San Francisco, California 94080

United States of America

Phone: +1.650.695.0677

Number of Employees:

http://www.lyell.com

Description

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.